Brainwaves Oscillations as a Potential Biomarker for Major Depression Disorder Risk

Clin EEG Neurosci. 2020 Jan;51(1):3-9. doi: 10.1177/1550059419876807. Epub 2019 Sep 20.

Abstract

Major depressive disorder (MDD) is a multidimensional disorder that is characterized by the presence of alterations in mood, cognitive capacity, sensorimotor, and homeostatic functions. Given that about half of the patients diagnosed with MDD do not respond to the various current treatments, new techniques are being sought to predict not only the course of the disease but also the characteristics that differentiate responders from non-responders. Using the electroencephalogram, a noninvasive and inexpensive tool, most studies have proposed that patients with MDD have some lateralization in brain electrical activity, with alterations in alpha and theta rhythms being observed, which would be related to dysfunctions in emotional capacity such as the absence or presence of responses to the different existing treatments. These alterations help in the identification of subjects at high risk of suffering from depression, in the differentiation into responders and nonresponders to various therapies (pharmacological, electroconvulsive therapy, and so on), as well as to establish in which period of the disease the treatment will be more effective. Although the data are still inconclusive and more research is needed, these alpha and theta neurophysiological markers could support future clinical practice when it comes to establishing an early diagnosis and treating state disorders more successfully and accurately of mood disorders.

Keywords: EEG; alpha oscillation; brainwaves; major depressive disorder; theta oscillation.

Publication types

  • Review

MeSH terms

  • Affect / physiology
  • Animals
  • Biomarkers / analysis
  • Brain Waves / physiology*
  • Depression / physiopathology*
  • Depressive Disorder, Major / physiopathology*
  • Humans
  • Theta Rhythm / physiology*

Substances

  • Biomarkers